Takeda Pharmaceutical Co. - Providence Business News

Home Tags Takeda Pharmaceutical Co.

ProThera enters agreement with Takeda for acute inflammatory condition treatment development

Health Services 04/23/2020

PROVIDENCE – ProThera Biologics Inc. has entered into a global licensing agreement with Takeda Pharmaceutical Co. Ltd. to develop a novel plasma-derived treatment of...

- Featured Event -

Latest News

CHUGGING ALONG: Matt Bosgraaf, right, owner of the Kayak Centre in North Kingstown, adjusts the pedal drive system on a fishing kayak in the store’s showroom. With him is John Van Ness, the store’s product specialist. Bosgraaf says the business is growing, helped by the recent acquisition of a kayak rental business.  PBN PHOTO/ELIZABETH GRAHAM

AT WHAT COSTS? PBN survey: Businesses haven’t lost all hope despite...

09/25/2026

POWERFUL PAIR: Solid State Power Corp. manufactures batteries for boats and aquatic vessels, drones, mining equipment, data center backup systems and scientific equipment, and ships them worldwide. Pictured from left are Phil Calef, father of founder and CEO Tom Calef, and assembly technician Jaquir Som at the company’s Pawtucket manufacturing facility. PBN PHOTO/ MICHAEL SALERNO

Meet the Makers: Pawtucket battery maker takes power to the extreme

09/25/2026

COLLABORATIVE CONFERENCE: Joseph Devine, center, president of Axiotrop LLC, meets with Dewetron Inc. Head of Operations Albon Redzepi, left, and marketing specialist Gabriella Scott at Axiotrop’s Narragansett office.  PBN PHOTO/ELIZABETH GRAHAM

Pentagon rule drives Axiotrop growth

09/25/2026

From small beginnings to a bright future

09/25/2026

Career Pathways: Nishita Roy-Pope, CEO of Courage Builder in North Kingstown, builds career pathways connecting Rhode island students to fast-growing fields such as the blue economy.  PBN PHOTO/ELIZABETH GRAHAM

Courage Builder for RI’s workforce

09/25/2026

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.